Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL NEUROSURGERY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 SOURCE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 INDUSTRIAL INSIGHTS:
4.4 CONCLUSION
5 REGULATIONS OF THE GLOBAL NEUROSURGERY MARKET
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 TECHNOLOGICAL ADVANCEMENT IN NEUROSURGERY
6.1.2 RISING PREVALENCE OF NEUROLOGICAL CONDITIONS
6.1.3 DEVELOPMENTS IN SURGICAL EQUIPMENT
6.2 RESTRAINTS
6.2.1 THE HIGH COST ASSOCIATED WITH NEUROSURGERIES AND EQUIPMENT
6.2.2 UNFAVOURABLE REIMBURSEMENT POLICIES
6.3 OPPORTUNITIES
6.3.1 RISING AWARENESS ABOUT NEUROLOGICAL DISORDERS
6.3.2 INCREASING NUMBER OF KEY PLAYERS IN MARKET
6.3.3 ADVANCE PRODUCT DEVELOPMENT AND LAUNCHES IN RECENT YEARS
6.4 CHALLENGES
6.4.1 ALTERNATIVE TREATMENTS FOR NEUROLOGICAL DISEASE
6.4.2 STRINGENT REGULATIONS FOR APPROVAL OF MEDICAL DEVICES
7 GLOBAL NEUROSURGERY MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 NEUROSURGERY DEVICES
7.2.1 NEUROMODULATION DEVICES
7.2.1.1 INTERNAL NEUROMODULATION DEVICES
7.2.1.1.1 SPINAL CORD STIMULATION DEVICES
7.2.1.1.1.1 RECHARGEABLE
7.2.1.1.1.2 NON- RECHARGEABLE
7.2.1.1.2 DEEP BRAIN STIMULATION DEVICES
7.2.1.1.2.1 SINGLE-CHANNEL DEEP BRAIN STIMULATION
7.2.1.1.2.2 DUAL-CHANNEL DEEP BRAIN STIMULATION
7.2.1.1.3 SACRAL NERVE STIMULATION DEVICES
7.2.1.1.3.1 IMPLANTABLE
7.2.1.1.3.2 EXTERNAL
7.2.1.1.4 VAGUS NERVE STIMULATION DEVICES
7.2.1.1.4.1 INVASIVE
7.2.1.1.4.2 EXTERNAL
7.2.1.1.5 GASTRIC ELECTRICAL STIMULATION DEVICES
7.2.1.1.5.1 LOW FREQUENCY GASTRIC ELECTRICAL STIMULATORS
7.2.1.1.5.2 HIGH FREQUENCY GASTRIC ELECTRICAL STIMULATORS
7.2.1.1.6 EXTERNAL NEUROMODULATION DEVICES
7.2.1.1.6.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)
7.2.1.1.6.2 TRANSCRANIAL MAGNETIC STIMULATION (TMS)
7.2.1.1.6.3 OTHERS
7.2.2 NEURO-INTERVENTIONAL DEVICES
7.2.2.1 EMBOLIZATION COILS
7.2.2.1.1 DETACHABLE
7.2.2.1.2 PUSHABLE
7.2.2.2 CAROTID STENTS
7.2.2.3 INTRACRANIAL STENTS
7.2.2.4 NEUROVASCULAR THROMBECTOMY
7.2.2.4.1 COIL RETRIEVERS
7.2.2.4.2 ASPIRATION DEVICES
7.2.2.4.3 STENT RETRIEVERS
7.2.2.5 INTRASSACULAR DEVICES
7.2.2.6 BALLOONS
7.2.2.7 OTHERS
7.2.3 NEUROSURGERY SURGICAL POWER TOOLS
7.2.3.1 DRILL
7.2.3.1.1 PNEUMATIC NEUROSURGICAL DRILLS
7.2.3.1.2 ELECTRICAL NEUROSURGICAL DRILLS
7.2.3.2 SAW
7.2.3.3 OTHERS
7.2.4 NEUROSURGICAL NAVIGATION SYSTEMS
7.2.5 CEREBROSPINAL FLUID (CSF) MANAGEMENT DEVICES
7.2.5.1 CSF SHUNTS
7.2.5.2 EXTERNAL DRAINAGE SYSTEM
7.2.6 NEUROSURGICAL MICROSCOPE
7.2.7 CRANIAL STABILIZATION
7.2.8 NEUROENDOSCOPY DEVICES
7.2.9 INTRA OPERATIVE IMAGING
7.2.10 BRAIN MONITORING
7.2.11 NEUROSURGICAL EVACUATION DEVICES
7.2.12 STEREOTACTIC SYSTEMS
7.2.13 ULTRASONIC ASPIRATOR
7.2.14 BIPOLAR EQUIPMENT
7.3 NEUROSURGERY SOFTWARE
7.3.1 IMAGING NEUROSURGERY SOFTWARE
7.3.2 PRE-OPERATION PLANNING NEUROSURGERY SOFTWARE
7.3.3 OTHERS
7.4 CONSUMABLES
8 GLOBAL NEUROSURGERY MARKET, BY AGE GROUP
8.1 OVERVIEW
8.2 PEDIATRIC
8.3 ADULT
8.4 GERIATRIC
9 GLOBAL NEUROSURGERY MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 BRAIN TUMORS
9.3 TRAUMA SURGERY
9.4 SPINE SURGERY
9.5 PARKINSON’S DISEASE AND TREMORS
9.6 PERIPHERAL NERVE SURGERY
9.7 EPILEPSY
9.8 FUNCTIONAL NEUROSURGERY
9.9 CAROTID ARTERY BLOCKAGE/STENOSIS
9.1 INTRAOPERATIVE ANGIOGRAPHY
9.11 CEREBROVASCULAR SURGERY
9.12 ANEURYSMS
9.13 PITUITARY TUMORS
9.14 RADIOSURGERY
9.15 STEREOTACTIC NEUROSURGERY
9.16 CORTICAL MAPPING
9.17 ARTERIOVENOUS MALFUNCTION (AVM)
9.18 SKULL BASE SURGERY
9.19 TRIGEMINAL NEURALGIA
9.2 OTHERS
10 GLOBAL NEUROSURGERY MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.2.1 ACUTE CARE HOSPITALS
10.2.2 LONG-TERM CARE HOSPITALS
10.2.3 NURSING FACILITIES
10.2.4 REHABILITATION CENTERS
10.3 RESEARCH CENTERS
10.4 NEUROSURGERY CENTERS
10.5 AMBULATORY SURGICAL CENTERS (ASCS)
10.6 OTHERS
11 GLOBAL NEUROSURGERY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 THIRD PARTY DISTRIBUTORS
11.4 OTHERS
12 GLOBAL NEUROSURGERY MARKET, BY REGION
12.1 OVERVIEW
12.2 NORTH AMERICA
12.2.1 U.S.
12.2.2 CANADA
12.2.3 MEXICO
12.3 EUROPE
12.3.1 GERMANY
12.3.2 FRANCE
12.3.3 U.K.
12.3.4 ITALY
12.3.5 RUSSIA
12.3.6 SPAIN
12.3.7 TURKEY
12.3.8 NETHERLANDS
12.3.9 SWITZERLAND
12.3.10 BELGIUM
12.3.11 REST OF EUROPE
12.4 ASIA-PACIFIC
12.4.1 CHINA
12.4.2 JAPAN
12.4.3 SOUTH KOREA
12.4.4 INDIA
12.4.5 AUSTRALIA
12.4.6 SINGAPORE
12.4.7 THAILAND
12.4.8 MALAYSIA
12.4.9 INDONESIA
12.4.10 PHILIPPINES
12.4.11 REST OF ASIA-PACIFIC
12.5 SOUTH AMERICA
12.5.1 BRAZIL
12.5.2 ARGENTINA
12.5.3 REST OF SOUTH AMERICA
12.6 MIDDLE EAST AND AFRICA
12.6.1 SOUTH AFRICA
12.6.2 SAUDI ARABIA
12.6.3 UAE
12.6.4 EGYPT
12.6.5 ISRAEL
12.6.6 REST OF MIDDLE EAST AND AFRICA
13 GLOBAL NEUROSURGERY MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: GLOBAL
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
13.3 COMPANY SHARE ANALYSIS: EUROPE
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 MEDTRONIC
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 STRYKER
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 ABBOTT
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 BOSTON SCIENTIFIC CORPORATION OR ITS AFFILIATES.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 INTEGRA LIFESCIENCES (2021)
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 ADEOR MEDICAL AG
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENTS
15.7 ADVANTIS MEDICAL IMAGING
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 ALEVA NEUROTHERAPEUTICS
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENTS
15.9 ANT NEURO
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.1 B. BRAUN SE
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENTS
15.11 BIOINDUCTION
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 BRAINLAB AG
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENTS
15.13 ELEKTA
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENTS
15.14 EMS HANDELS GESELLSCHAFT MBH
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 INOMED MEDIZINTECHNIK GMBH
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 KARL STORZ SE & CO. KG
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 LEICA MICROSYSTEMS
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.18 LIVANOVA PLC
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENTS
15.19 NEVRO CORP.
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENTS
15.2 OPTOFINE INSTRUMENTS PVT. LTD.
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENTS
15.21 PENUMBRA, INC.
15.21.1 COMPANY SNAPSHOT
15.21.2 REVENUE ANALYSIS
15.21.3 PRODUCT PORTFOLIO
15.21.4 RECENT DEVELOPMENTS
15.22 RENISHAW PLC.
15.22.1 COMPANY SNAPSHOT
15.22.2 REVENUE ANALYSIS
15.22.3 PRODUCT PORTFOLIO
15.22.4 RECENT DEVELOPMENT
15.23 SYNAPSE BIOMEDICAL INC.
15.23.1 COMPANY SNAPSHOT
15.23.2 PRODUCT PORTFOLIO
15.23.3 RECENT DEVELOPMENT
15.24 TERUMO MEDICAL CORPORATION
15.24.1 COMPANY SNAPSHOT
15.24.2 REVENUE ANALYSIS
15.24.3 PRODUCT PORTFOLIO
15.24.4 RECENT DEVELOPMENTS
15.25 MACHIDA ENDOSCOPE CO., LTD.
15.25.1 COMPANY SNAPSHOT
15.25.2 PRODUCT PORTFOLIO
15.25.3 RECENT DEVELOPMENTS
15.26 NALU MEDICAL, INC.
15.26.1 COMPANY SNAPSHOT
15.26.2 PRODUCT PORTFOLIO
15.26.3 RECENT DEVELOPMENT
15.27 WALLABY MEDICAL
15.27.1 COMPANY SNAPSHOT
15.27.2 PRODUCT PORTFOLIO
15.27.3 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
List of Table
TABLE 1 GLOBAL NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 2 GLOBAL NEUROSURGERY DEVICES IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 GLOBAL NEUROSURGERY DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 4 GLOBAL NEUROMODULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 5 GLOBAL INTERNAL NEUROMODULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 6 GLOBAL SPINAL CORD STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 7 GLOBAL DEEP BRAIN STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 8 GLOBAL SACRAL NERVE STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 9 GLOBAL VAGUS NERVE STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 10 GLOBAL GASTRIC ELECTRICAL STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 11 GLOBAL EXTERNAL NEUROMODULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 12 GLOBAL NEURO-INTERVENTIONAL DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 13 GLOBAL EMBOLIZATION COILS IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 14 GLOBAL NEUROVASCULAR THROMBECTOMY IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 15 GLOBAL NEUROSURGICAL POWER TOOLS IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 16 GLOBAL DRILL IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 17 GLOBAL CEREBROSPINAL FLUID (CSF) MANAGEMENT DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 18 GLOBAL NEUROSURGERY SOFTWARE IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 GLOBAL NEUROSURGERY SOFTWARE IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 20 GLOBAL CONSUMABLES IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 GLOBAL NEUROSURGERY MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 22 GLOBAL PEDIATRIC IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 GLOBAL ADULT IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 GLOBAL GERIATRIC IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 GLOBAL NEUROSURGERY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 26 GLOBAL BRAIN TUMORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 GLOBAL TRAUMA SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 GLOBAL SPINE SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 GLOBAL PARKINSON’S DISEASE AND TREMORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 GLOBAL PERIPHERAL NERVE SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 GLOBAL EPILEPSY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 32 GLOBAL FUNCTIONAL NEUROSURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 GLOBAL CAROTID ARTERY BLOCKAGE/STENOSIS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 GLOBAL INTERAOPERATIVE ANGIOGRAPHY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 GLOBAL CEREBROVASCULAR SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 GLOBAL ANEURYSMS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 GLOBAL PITUITARY TUMORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 38 GLOBAL RADIOSURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 39 GLOBAL STEREOTACTIC NEUROSURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 40 GLOBAL CORTICAL MAPPING IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 GLOBAL ARTERIOVENOUS MALFUNCTION (AVM) IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 42 GLOBAL SKULL BASE SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 43 GLOBAL TRIGEMINAL NEURALGIA IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 44 GLOBAL OTHERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 45 GLOBAL NEUROSURGERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 46 GLOBAL HOSPITALS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 47 GLOBAL HOSPITALS IN NEUROSURGERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 48 GLOBAL RESEARCH CENTERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 49 GLOBAL NEUROSURGERY CENTERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 50 GLOBAL AMBULATORY SURGICAL CENTERS (ASCS) IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 51 GLOBAL OTHERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 52 GLOBAL NEUROSURGERY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 53 GLOBAL DIRECT TENDER IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 54 GLOBAL THIRD PARTY DISTRIBUTORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 55 GLOBAL OTHERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 GLOBAL NEUROSURGERY MARKET: SEGMENTATION
FIGURE 2 GLOBAL NEUROSURGERY MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL NEUROSURGERY MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL NEUROSURGERY MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 GLOBAL NEUROSURGERY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL NEUROSURGERY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL NEUROSURGERY MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 GLOBAL NEUROSURGERY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL NEUROSURGERY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL NEUROSURGERY MARKET: SEGMENTATION
FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL NEUROSURGERY MARKET, AND EUROPE IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 THE GROWING PREVALENCE OF NEUROLOGICAL DISEASES, EFFORTS TO DEVELOP THE APPLICATION BASE FOR NEUROMODULATION, AND THE BENEFITS OF NEUROENDOSCOPIC SURGERIES OVER CONVENTIONAL BRAIN SURGERIES ARE EXPECTED TO DRIVE THE GLOBAL NEUROSURGERY MARKET GROWTH IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 13 NEUROSURGERY DEVICES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL NEUROSURGERY MARKET IN 2022 & 2029
FIGURE 14 NORTH AMERICA IS THE FASTEST GROWING MARKET FOR NEUROSURGICAL PRODUCTS MANUFACTURERS IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND, CHALLENGES OF GLOBAL NEUROSURGERY MARKET
FIGURE 16 GLOBAL NEUROSURGERY MARKET: BY PRODUCT TYPE, 2021
FIGURE 17 GLOBAL NEUROSURGERY MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)
FIGURE 18 GLOBAL NEUROSURGERY MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 19 GLOBAL NEUROSURGERY MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 20 GLOBAL NEUROSURGERY MARKET: BY AGE GROUP, 2021
FIGURE 21 GLOBAL NEUROSURGERY MARKET: BY AGE GROUP, 2022-2029 (USD MILLION)
FIGURE 22 GLOBAL NEUROSURGERY MARKET: BY AGE GROUP, CAGR (2022-2029)
FIGURE 23 GLOBAL NEUROSURGERY MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 24 GLOBAL NEUROSURGERY MARKET: BY APPLICATION, 2021
FIGURE 25 GLOBAL NEUROSURGERY MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 26 GLOBAL NEUROSURGERY MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 27 GLOBAL NEUROSURGERY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 28 GLOBAL NEUROSURGERY MARKET: BY END USER, 2021
FIGURE 29 GLOBAL NEUROSURGERY MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 30 GLOBAL NEUROSURGERY MARKET: BY END USER, CAGR (2022-2029)
FIGURE 31 GLOBAL NEUROSURGERY MARKET: BY END USER, LIFELINE CURVE
FIGURE 32 GLOBAL NEUROSURGERY MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 33 GLOBAL NEUROSURGERY MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 34 GLOBAL NEUROSURGERY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 35 GLOBAL NEUROSURGERY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 36 GLOBAL NEUROSURGERY MARKET: SNAPSHOT (2021)
FIGURE 37 GLOBAL NEUROSURGERY MARKET: BY REGION (2021)
FIGURE 38 GLOBAL NEUROSURGERY MARKET: BY REGION (2022 & 2029)
FIGURE 39 GLOBAL NEUROSURGERY MARKET: BY REGION (2021 & 2029)
FIGURE 40 GLOBAL NEUROSURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 41 NORTH AMERICA NEUROSURGERY MARKET: SNAPSHOT (2021)
FIGURE 42 NORTH AMERICA NEUROSURGERY MARKET: BY COUNTRY (2021)
FIGURE 43 NORTH AMERICA NEUROSURGERY MARKET: BY PRODUCT COUNTRY (2022 & 2029)
FIGURE 44 NORTH AMERICA NEUROSURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 45 NORTH AMERICA NEUROSURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 46 EUROPE NEUROSURGERY MARKET: SNAPSHOT (2021)
FIGURE 47 EUROPE NEUROSURGERY MARKET: BY COUNTRY (2021)
FIGURE 48 EUROPE NEUROSURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 49 EUROPE NEUROSURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 50 EUROPE NEUROSURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 51 ASIA-PACIFIC NEUROSURGERY MARKET: SNAPSHOT (2021)
FIGURE 52 ASIA-PACIFIC NEUROSURGERY MARKET: BY COUNTRY (2021)
FIGURE 53 ASIA-PACIFIC NEUROSURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 54 ASIA-PACIFIC NEUROSURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 55 ASIA-PACIFIC NEUROSURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 56 SOUTH AMERICA NEUROSURGERY MARKET: SNAPSHOT (2021)
FIGURE 57 SOUTH AMERICA NEUROSURGERY MARKET: BY COUNTRY (2021)
FIGURE 58 SOUTH AMERICA NEUROSURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 59 SOUTH AMERICA NEUROSURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 60 SOUTH AMERICA NEUROSURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 61 MIDDLE EAST AND AFRICA NEUROSURGERY MARKET: SNAPSHOT (2021)
FIGURE 62 MIDDLE EAST AND AFRICA NEUROSURGERY MARKET: BY COUNTRY (2021)
FIGURE 63 MIDDLE EAST AND AFRICA NEUROSURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 64 MIDDLE EAST AND AFRICA NEUROSURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 65 MIDDLE EAST AND AFRICA NEUROSURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 66 GLOBAL NEUROSURGERY MARKET: COMPANY SHARE 2021 (%)
FIGURE 67 NORTH AMERICA NEUROSURGERY MARKET: COMPANY SHARE 2021 (%)
FIGURE 68 EUROPE NEUROSURGERY MARKET: COMPANY SHARE 2021 (%)
FIGURE 69 ASIA-PACIFIC NEUROSURGERY MARKET: COMPANY SHARE 2021 (%)
